Nexstim Plc announces having received an NBS 5+ system order from a customer in the United States. This is the customer’s second NBS 5+ system.
Nexstim released the NBS5+ system in the United States in late 2021. The NBS 5+ system combines the capabilities of Nexstim’s NBS and NBT® systems, enabling the delivery of both diagnostic and therapeutic applications.
Mikko Karvinen, CEO of Nexstim, comments: “The NBS 5+ system business is an increasingly important part of our operations in the United States. We are seeing interest among our customers in the possibility of having multiple departments utilize the same system. We are very glad that in the case of this customer, excellent experiences with the NBS 5+ system led to placing an order for another system.”
